AnaptysBio Inc (NASDAQ:ANAB) shares, rose in value on Wednesday, March 26, with the stock price down by -1.36% to the previous day’s close as strong demand from buyers drove the stock to $18.19.
Actively observing the price movement in the last trading, the stock closed the session at $18.44, falling within a range of $17.6 and $18.46. The value of beta (5-year monthly) was 0.025. Referring to stock’s 52-week performance, its high was $41.31, and the low was $12.21. On the whole, ANAB has fluctuated by 5.82% over the past month.
With the market capitalization of AnaptysBio Inc currently standing at about $557.83 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-26.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ANAB’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ANAB currently trading nearly 7.88% and 7.83% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 55.93, while the 7-day volatility ratio is showing 9.37% which for the 30-day chart, stands at 9.67%. Furthermore, AnaptysBio Inc (ANAB)’s beta value is -0.07, and its average true range (ATR) is 1.53.
A comparison of AnaptysBio Inc (ANAB) with its peers suggests the former has fared considerably weaker in the market. ANAB showed an intraday change of -1.36% in last session, and over the past year, it shrunk by -16.06%%.
Data on historical trading for AnaptysBio Inc (NASDAQ:ANAB) indicates that the trading volumes over the past 10 days have averaged 0.99 and over the past 3 months, they’ve averaged 994.01K. According to company’s latest data on outstanding shares, there are 30.47 million shares outstanding.
Nearly 7.73% of AnaptysBio Inc’s shares belong to company insiders and institutional investors own 124.12% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9.8 million shares as on 2025-03-14, resulting in a short ratio of 12.83. According to the data, the short interest in AnaptysBio Inc (ANAB) stood at 4352.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 9.31 million. The stock has risen by 37.39% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ANAB stock heading into the next quarter.
